AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets

Journal of Virology

Volumn 89, Issue 8, 2015, Pages 4387-4404

  Neveu, Gregory ^a   Ziv Av, Amotz ^a,b   Barouch Bentov, Rina ^a   Berkerman, Elena ^a   Mulholland, Jon ^a   Einav, Shirit ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN 2 ASSOCIATED PROTEIN KINASE 1; CYCLIN G ASSOCIATED KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; PROTEIN KINASE; SUNITINIB; UNCLASSIFIED DRUG; VIRUS RNA; AAK1 PROTEIN, HUMAN; GAK PROTEIN, HUMAN; INDOLE DERIVATIVE; LUCIFERASE; PROTEIN SERINE THREONINE KINASE; PYRROLE DERIVATIVE; QUINAZOLINE DERIVATIVE; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOCYTOSIS; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOFLUORESCENCE MICROSCOPY; INTERNALIZATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; RNA REPLICATION; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS PARTICLE; WESTERN BLOTTING; CELL LINE; FLUORESCENCE MICROSCOPY; GENETICS; HEPACIVIRUS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

HEPATITIS C VIRUS;

BLOTTING, WESTERN; CELL LINE; ERLOTINIB HYDROCHLORIDE; HEPACIVIRUS; HEPATITIS C; HUMANS; INDOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MICROSCOPY, FLUORESCENCE; PLASMIDS; PROTEIN-SERINE-THREONINE KINASES; PYRROLES; QUINAZOLINES; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS INTERNALIZATION;

EID: 84925424667     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02705-14     Document Type: Article

References (117)

1. Lavanchy D. 2009. The global burden of hepatitis C. Liver Int 29(Suppl 1):74-81. http://dx.doi.org/10.1111/j.1478-3231.2008.01934.x.
2. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132:296-305. http://dx.doi.org/10.7326/0003-4819-132-4-200002150-00008.
3. Lemon SM, Walker C, Alter MJ, Yi M. 2007. Hepatitis C viruses, p 1253-1304. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Soriano V, Vispo E, Poveda E, Labarga P, Martin Carbonero L, Fernandez Montero J, Barreiro P. 2011. Directly acting antivirals against hepatitis C virus. J Antimicrob Chemother 66:1673-1686. http://dx.doi.org/10.1093/jac/dkr215.
5. Pawlotsky J-M. 2013. Treatment of chronic hepatitis C: current and future. Curr Top Microbiol Immunol 369:321-342. http://dx.doi.org/10.1007/978-3-642-27340-7_13.
6. Lange CM, Zeuzem S. 2013. Perspectives and challenges of interferonfree therapy for chronic hepatitis C. J Hepatol 58:583-592. http://dx.doi.org/10.1016/j.jhep.2012.10.019.
7. Bartenschlager R, Lohmann V. 2000. Replication of hepatitis C virus. J Gen Virol 81:1631-1648.
8. Branch AD. 2000. Hepatitis C virus RNA codes for proteins and replicates: does it also trigger the interferon response? Semin Liver Dis 20:57-68. http://dx.doi.org/10.1055/s-2000-9502.
9. Reed KE, Rice CM. 2000. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55-84. http://dx.doi.org/10.1007/978-3-642-59605-6_4.
10. Lindenbach B, Rice C. 2013. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 11:688-700. http://dx.doi.org/10.1038/nrmicro3098.
11. Drummer HE, Maerz A, Poumbourios P. 2003. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 546: 385-390. http://dx.doi.org/10.1016/S0014-5793(03)00635-5.
12. Bartosch B, Dubuisson J, Cosset F-L. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633-642. http://dx.doi.org/10.1084/jem.20021756.
13. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA. 2003. Hepatitis C virus glycoproteins mediate pHdependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100:7271-7276. http://dx.doi.org/10.1073/pnas.0832180100.
14. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. http://dx.doi.org/10.1126/science.1114016.
15. Gastaminza P, Kapadia SB, Chisari FV. 2006. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 80:11074-11081. http://dx.doi.org/10.1128/JVI.01150-06.
16. Thomssen R, Bonk S, Propfe C, Heermann KH, Köchel HG, Uy A. 1992. Association of hepatitis C virus in human sera with β-lipoprotein. Med Microbiol Immunol 181:293-300. http://dx.doi.org/10.1007/BF00198849.
17. André P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Bréchot C, Paranhos-Baccalà G, Lotteau V. 2002. characterization of low-and very-low-density hepatitis C virus RNAcontaining particles. J Virol 76:6919-6928. http://dx.doi.org/10.1128/JVI.76.14.6919-6928.2002.
18. Diaz O, Delers F, Maynard M, Demignot S, Zoulim F, Chambaz J, Trépo C, Lotteau V, André P. 2006. Preferential association of hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol 87:2983-2991. http://dx.doi.org/10.1099/vir.0.82033-0.
19. Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL. 2006. Association between hepatitis C virus and very-lowdensity lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80:2418-2428. http://dx.doi.org/10.1128/JVI.80.5.2418-2428.2006.
20. Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E, Boson B, Cosset F-L, Patel AH, Blum HE, Baumert TF. 2006. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 80:10579-10590. http://dx.doi.org/10.1128/JVI.00941-06.
21. Morikawa K, Zhao Z, Date T, Miyamoto M, Murayama A, Akazawa D, Tanabe J, Sone S, Wakita T. 2007. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J Med Virol 79:714-723. http://dx.doi.org/10.1002/jmv.20842.
22. Molina S, Castet V, Fournier-Wirth C, Pichard-Garcia L, Avner R, Harats D, Roitelman J, Barbaras R, Graber P, Ghersa P, Smolarsky M, Funaro A, Malavasi F, Larrey D, Coste J, Fabre J-M, Sa-Cunha A, Maurel P. 2007. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 46:411-419. http://dx.doi.org/10.1016/j.jhep.2006.09.024.
23. Monazahian M, Böhme I, Bonk S, Koch A, Scholz C, Grethe S, Thomssen R. 1999. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57:223-229. http://dx.doi.org/10.1002/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO;2-4.
24. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941. http://dx.doi.org/10.1126/science.282.5390.938.
25. Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV. 2007. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol 81:374-383. http://dx.doi.org/10.1128/JVI.01134-06.
26. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. 2004. CD81 is required for hepatitis C Virus glycoprotein-mediated viral infection. J Virol 78:1448-1455. http://dx.doi.org/10.1128/JVI.78.3.1448-1455.2004.
27. McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P. 2004. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol 78:8496-8505. http://dx.doi.org/10.1128/JVI.78.16.8496-8505.2004.
28. Dreux M, Dao Thi VL, Fresquet J, Guarin M, Julia Z, Verney G, Durantel D, Zoulim F, Lavillette D, Cosset F-L, Bartosch B. 2009. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra-and extra-cellular domains. PLoS Pathog 5:e1000310. http://dx.doi.org/10.1371/journal.ppat.1000310.
29. Scarselli E, Ansuini H, Cerino R, Roccasecca R, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017-5025. http://dx.doi.org/10.1093/emboj/cdf529.
30. Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset F-L, Wakita T, Jaeck D, Doffoel M, Royer C, Soulier E, Schvoerer E, Schuster C, Stoll-Keller F, Bartenschlager R, Pietschmann T, Barth H, Baumert TF. 2007. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46:1722-1731. http://dx.doi.org/10.1002/hep.21994.
31. Grove J, Huby T, Stamataki Z, Vanwolleghem T, Meuleman P, Farquhar M, Schwarz A, Moreau M, Owen JS, Leroux-Roels G, Balfe P, McKeating JA. 2007. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol 81:3162-3169. http://dx.doi.org/10.1128/JVI.02356-06.
32. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-886. http://dx.doi.org/10.1038/nature07684.
33. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T. 2009. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 83:2011-2014. http://dx.doi.org/10.1128/JVI.01888-08.
34. Benedicto I, Molina-Jiménez F, Bartosch B, Cosset F-L, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL. 2009. The tight junction-associated protein occludin is required for a postbinding step in hepatitisCvirus entry and infection. J Virol 83:8012-8020. http://dx.doi.org/10.1128/JVI.00038-09.
35. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805. http://dx.doi.org/10.1038/nature05654.
36. Meertens L, Bertaux C, Cukierman L, Cormier E, Lavillette D, Cosset F-L, Dragic T. 2008. The tight junction proteins claudin-1,-6, and-9 are entry cofactors for hepatitis C virus. J Virol 82:3555-3560. http://dx.doi.org/10.1128/JVI.01977-07.
37. Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J, Song X, Ding M, Deng H. 2007. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J Virol 81:12465-12471. http://dx.doi.org/10.1128/JVI.01457-07.
38. Lupberger J, Zeisel M, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee C, Turek M, Gorke S, Royer C, Fischer B, Zahid M, Lavillette D, Fresquet J, Cosset F-L, Rothenberg SM, Pietschmann T, Patel A, Pessaux P, Doffol M, Raffelsberger W, Poch O, McKeating J, Brino L, Baumert T. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17:589-595. http://dx.doi.org/10.1038/nm.2341.
39. Sainz B, Barretto N, Martin D, Hiraga N, Imamura M, Hussain S, Marsh K, Yu X, Chayama K, Alrefai W, Uprichard S. 2012. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18:281-285. http://dx.doi.org/10.1038/nm.2581.
40. Martin DN, Uprichard SL. 2013. Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci U S A 110:10777-10782. http://dx.doi.org/10.1073/pnas.1301764110.
41. Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris Helen J, Barnes A, Florentin J, Tawar Rajiv G, Xiao F, Turek M, Durand Sarah C, Duong François HT, Heim Markus H, Cosset F-L, Hirsch I, Samuel D, Brino L, Zeisel Mirjam B, Le Naour F, McKeating Jane A, Baumert Thomas F. 2013. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe 13:302-313. http://dx.doi.org/10.1016/j.chom.2013.02.006.
42. Farquhar MJ, Hu K, Harris HJ, Davis C, Brimacombe CL, Fletcher SJ, Baumert TF, Rappoport JZ, Balfe P, McKeating JA. 2012. Hepatitis C virus induces CD81 and claudin-1 endocytosis. J Virol 86:4305-4316. http://dx.doi.org/10.1128/JVI.06996-11.
43. Farquhar MJ, Harris HJ, Diskar M, Jones S, Mee CJ, Nielsen SU, Brimacombe CL, Molina S, Toms GL, Maurel P, Howl J, Herberg FW, van IJzendoorn SCD, Balfe P, McKeating JA. 2008. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J Virol 82:8797-8811. http://dx.doi.org/10.1128/JVI.00592-08.
44. Brazzoli M, Bianchi A, Filippini S, Weiner A, Zhu Q, Pizza M, Crotta S. 2008. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J Virol 82:8316-8329. http://dx.doi.org/10.1128/JVI.00665-08.
45. Codran A, Royer C, Jaeck D, Bastien-Valle M, Baumert TF, Kieny MP, Pereira CA, Martin J-P. 2006. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J Gen Virol 87:2583-2593. http://dx.doi.org/10.1099/vir.0.81710-0.
46. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, Rouille Y. 2006. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80:6964-6972. http://dx.doi.org/10.1128/JVI.00024-06.
47. Meertens L, Bertaux C, Dragic T. 2006. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80:11571-11578. http://dx.doi.org/10.1128/JVI.01717-06.
48. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. 2006. Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80:1734-1741. http://dx.doi.org/10.1128/JVI.80.4.1734-1741.2006.
49. Coller K, Berger K, Heaton N, Cooper J, Yoon R, Randall G. 2009. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog 5:e1000702. http://dx.doi.org/10.1371/journal.ppat.1000702.
50. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80:5308-5320. http://dx.doi.org/10.1128/JVI.02460-05.
51. Moradpour D, Penin Fo Rice CM. 2007. Replication of hepatitis C virus. Nat Rev Microbiol 5:453-463. http://dx.doi.org/10.1038/nrmicro 1645.
52. Conner S, Schmid S. 2003. Regulated portals of entry into the cell. Nature 422:37-44. http://dx.doi.org/10.1038/nature01451.
53. Brodsky F. 2012. Diversity of clathrin function: new tricks for an old protein. Annu Rev Cell Dev Biol 28:309-336. http://dx.doi.org/10.1146/annurev-cellbio-101011-155716.
54. Owen D, Collins B, Evans P. 2004. Adaptors for clathrin coats: structure and function. Annu Rev Cell Dev Biol 20:153-191. http://dx.doi.org/10.1146/annurev.cellbio.20.010403.104543.
55. Ohno H. 2006. Clathrin-associated adaptor protein complexes. J Cell Sci 119:3719-3721. http://dx.doi.org/10.1242/jcs.03085.
56. Ohno H, Stewart J, Fournier MC, Bosshart H, Rhee I, Miyatake S, Saito T, Gallusser A, Kirchhausen T, Bonifacino JS. 1995. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269:1872-1875. http://dx.doi.org/10.1126/science.7569928.
57. Pearse BM. 1988. Receptors compete for adaptors found in plasma membrane coated pits. EMBO J 7:3331-3336.
58. Boll W, Ohno H, Songyang Z, Rapoport I, Cantley LC, Bonifacino JS, Kirchhausen T. 1996. Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes. EMBO J 15:5789-5795.
59. Lee D-W, Zhao X, Zhang F, Eisenberg E, Greene LE. 2005. Depletion of GAK/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors. J Cell Sci 118:4311-4321. http://dx.doi.org/10.1242/jcs.02548.
60. Ricotta D, Conner SD, Schmid SL, von Figura K, Honing S. 2002. Phosphorylation of the AP2 μ subunit by AAK1 mediates high affinity binding to membrane protein sorting signals. J Cell Biol 156:791-795. http://dx.doi.org/10.1083/jcb.200111068.
61. Korolchuk VI, Banting G. 2002. CK2 and GAK/auxilin2 are major protein kinases in clathrin-coated vesicles. Traffic 3:428-439. http://dx.doi.org/10.1034/j.1600-0854.2002.30606.x.
62. Zhang CX, Engqvist-Goldstein ÅE, Carreno S, Owen DJ, Smythe E, Drubin DG. 2005. Multiple roles for cyclin G-associated kinase in clath-rin-mediated sorting events. Traffic 6:1103-1113. http://dx.doi.org/10.1111/j.1600-0854.2005.00346.x.
63. Umeda A, Meyerholz A, Ungewickell E. 2000. Identification of the universal cofactor (auxilin 2) in clathrin coat dissociation. Eur J Cell Biol 79:336-342. http://dx.doi.org/10.1078/S0171-9335(04)70037-0.
64. Conner S, Schröter T, Schmid S. 2003. AAK1-mediated micro2 phosphorylation is stimulated by assembled clathrin. Traffic 4:885-890. http://dx.doi.org/10.1046/j.1398-9219.2003.0142.x.
65. Zhao X, Greener T, Al-Hasani H, Cushman SW, Eisenberg E, Greene LE. 2001. Expression of auxilin or AP180 inhibits endocytosis by mislocalizing clathrin: evidence for formation of nascent pits containing AP1 or AP2 but not clathrin. J Cell Sci 114:353-365.
66. Traub LM. 2003. Sorting it out: AP-2 and alternate clathrin adaptors in endocytic cargo selection. J Cell Biol 163:203-208. http://dx.doi.org/10.1083/jcb.200309175.
67. Sorensen E, Conner S. 2008. AAK1 regulates Numb function at an early step in clathrin-mediated endocytosis. Traffic 9:1791-1800. http://dx.doi.org/10.1111/j.1600-0854.2008.00790.x.
68. Henderson DM, Conner SD. 2007. A Novel AAK1 splice variant functions at multiple steps of the endocytic pathway. Mol Biol Cell 18:2698-2706. http://dx.doi.org/10.1091/mbc.E06-09-0831.
69. Zhang L, Gjoerup O, Roberts TM. 2004. The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling. Proc Natl Acad Sci U S A 101:10296-10301. http://dx.doi.org/10.1073/pnas.0403175101.
70. Smith CA, Dho SE, Donaldson J, Tepass U, McGlade CJ. 2004. The cell fate determinant Numb interacts with EHD/Rme-1 family proteins and has a role in endocytic recycling. Mol Biol Cell 15:3698-3708. http://dx.doi.org/10.1091/mbc.E04-01-0026.
71. Santolini E, Puri C, Salcini AE, Gagliani MC, Pelicci PG, Tacchetti C, Di Fiore PP. 2000. Numb is an endocytic protein. J Cell Biol 151:1345-1352. http://dx.doi.org/10.1083/jcb.151.6.1345.
72. Salcini AE, Confalonieri S, Doria M, Santolini E, Tassi E, Minenkova O, Cesareni G, Pelicci PG, Di Fiore PP. 1997. Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module. Genes Dev 11:2239-2249. http://dx.doi.org/10.1101/gad.11.17.2239.
73. Gupta-Rossi N, Ortica S, Meas-Yedid V, Heuss S, Moretti J, Olivo-Marin J-C, Israël A. 2011. The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway. J Biol Chem 286:18720-18730. http://dx.doi.org/10.1074/jbc.M110.190769.
74. Chi S, Cao H, Wang Y, McNiven MA. 2011. Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15. J Biol Chem 286:35196-35208. http://dx.doi.org/10.1074/jbc.M111.247577.
75. Diao J, Pantua H, Ngu H, Komuves L, Diehl L, Schaefer G, Kapadia SB. 2012. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J Virol 86:10935-10949. http://dx.doi.org/10.1128/JVI.00750-12.
76. Neveu G, Barouch-Bentov R, Ziv-Av A, Gerber D, Jacob Y, Einav S. 2012. Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly. PLoS Pathog 8:e1002845. http://dx.doi.org/10.1371/journal.ppat.1002845.
77. Rual J-F, Hirozane-Kishikawa T, Hao T, Bertin N, Li S, Dricot A, Li N, Rosenberg J, Lamesch P, Vidalain P-O, Clingingsmith T, Hartley J, Esposito D, Cheo D, Moore T, Simmons B, Sequerra R, Bosak S, Doucette-Stamm L, Le Peuch C, Vandenhaute J, Cusick M, Albala J, Hill D, Vidal M. 2004. Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res 14:2128-2135. http://dx.doi.org/10.1101/gr.2973604.
78. Cassonnet P, Rolloy C, Neveu G, Vidalain PO, Chnatier T, Pellet J, Jones L, Muller M, Demeret C, Gaud G, Vuillier F, Lotteau V, Tangy F, Favre M, Jacob Y. 2011. Benchmarking a luciferase complementation assay for detecting protein complexes. Nat Methods 8:990-992. http://dx.doi.org/10.1038/nmeth.1773.
79. Kametaka S, Moriyama K, Burgos PV, Eisenberg E, Greene LE, Mattera R, Bonifacino JS. 2007. Canonical interaction of cyclin G associated kinase with adaptor protein 1 regulates lysosomal enzyme sorting. Mol Biol Cell 18:2991-3001. http://dx.doi.org/10.1091/mbc.E06-12-1162.
80. Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G, Di Fiore PP. 2004. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167:215-221. http://dx.doi.org/10.1083/jcb.200406140.
81. Murray CL, Jones CT, Tassello J, Rice CM. 2007. Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol 81:10220-10231. http://dx.doi.org/10.1128/JVI.00793-07.
82. Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G. 2012. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J Virol 86:7256-7267. http://dx.doi.org/10.1128/JVI.07222-11.
83. Prichard MN, Shipman C. 1996. Analysis of combinations of antiviral drugs and design of effective multidrug therapies. Antivir Ther 1:9-20.
84. Prichard MK, Aseltine KR, Shipman C, Jr. 1993. MacSynergy II, version 1.0. User's manual. University of Michigan, Ann Arbor, MI.
85. Prichard MN, Shipman C. 1990. A three-dimensional model to analyze drug-drug interactions. Antiviral Res 14:181-205. http://dx.doi.org/10.1016/0166-3542(90)90001-N.
86. Liberali P, Kakkonen E, Turacchio G, Valente C, Spaar A, Perinetti G, Böckmann RA, Corda D, Colanzi A, Marjomaki V, Luini A. 2008. The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J 27:970-981. http://dx.doi.org/10.1038/emboj.2008.59.
87. Matsuda M, Suzuki R, Kataoka C, Watashi K, Aizaki H, Kato N, Matsuura Y, Suzuki T, Wakita T. 2014. Alternative endocytosis pathway for productive entry of hepatitis C virus. J Gen Virol 95:2658-2667. http://dx.doi.org/10.1099/vir.0.068528-0.
88. Shi Q, Jiang J, Luo G. 2013. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J Virol 87:6866-6875. http://dx.doi.org/10.1128/JVI.03475-12.
89. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H. 1993. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67:1953-1958.
90. Nielsen E, Severin F, Backer JM, Hyman AA, Zerial M. 1999. Rab5 regulates motility of early endosomes on microtubules. Nat Cell Biol 1:376-382. http://dx.doi.org/10.1038/14075.
91. Helmuth JA, Burckhardt CJ, Greber UF, Sbalzarini IF. 2009. Shape reconstruction of subcellular structures from live cell fluorescence microscopy images. J Struct Biol 167:1-10. http://dx.doi.org/10.1016/j.jsb.2009.03.017.
92. Dunn KW, Kamocka MM, McDonald JH. 2011. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol 300:C723-C742. http://dx.doi.org/10.1152/ajpcell.00462.2010.
93. Park Sang Y, Guo X. 2014. Adaptor protein complexes and intracellular transport. Biosci Rep 34:e00123. http://dx.doi.org/10.1042/BSR20140069.
94. Helle F, Vieyres G, Elkrief L, Popescu C-I, Wychowski C, Descamps V, Castelain S, Roingeard P, Duverlie G, Dubuisson J. 2010. Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. J Virol 84:11905-11915. http://dx.doi.org/10.1128/JVI.01548-10.
95. Sainz B, Jr, Barretto N, Uprichard SL. 2009. Hepatitis C virus infection in phenotypically distinct Huh7 cell lines. PLoS One 4:e6561. http://dx.doi.org/10.1371/journal.pone.0006561.
96. 2+/calmodulin-dependent protein kinases. J Biol Chem 280:35108-35118. http://dx.doi.org/10.1074/jbc.M503912200.
97. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R, Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Morrison MJ, Pallares G, Patel HK, Pritchard S, Wodicka LM, Zarrinkar PP. 2008. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26:127-132. http://dx.doi.org/10.1038/nbt1358.
98. SuperNova Life Science. 2008. Human kinome heat map. SuperNoval Life Science, Auburn,WA.http://www.supernovalifescience.com/HM/HM%20 41.pdf.
99. Viaud J, Peterson JR. 2009. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Mol Cancer Ther 8:2559-2565. http://dx.doi.org/10.1158/1535-7163.MCT-09-0102.
100. Einav S, Sobol Hadas D, Gehrig E, Glenn JS. 2010. The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors. J Infect Dis 202:65-74. http://dx.doi.org/10.1086/653080.
101. Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, Hopkins CR, Evans PR, McMahon HT. 2001. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 291:1051-1055. http://dx.doi.org/10.1126/science.291.5506.1051.
102. Mishra SK, Agostinelli NR, Brett TJ, Mizukami I, Ross TS, Traub LM. 2001. Clathrin-and AP-2-binding sites in HIP1 uncover a general assembly role for endocytic accessory proteins. J Biol Chem 276:46230-46236. http://dx.doi.org/10.1074/jbc.M108177200.
103. Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, Traub LM. 2002. Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J 21:4915-4926. http://dx.doi.org/10.1093/emboj/cdf487.
104. Motley A, Bright NA, Seaman MNJ, Robinson MS. 2003. Clathrinmediated endocytosis in AP-2-depleted cells. J Cell Biol 162:909-918. http://dx.doi.org/10.1083/jcb.200305145.
105. Cureton DK, Massol RH, Saffarian S, Kirchhausen TL, Whelan SPJ. 2009. Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog 5:e1000394. http://dx.doi.org/10.1371/journal.ppat.1000394.
106. Lakadamyali M, Rust MJ, Zhuang X. 2006. Ligands for clathrinmediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124:997-1009. http://dx.doi.org/10.1016/j.cell.2005.12.038.
107. Chen C, Zhuang X. 2008. Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus. Proc Natl Acad Sci U S A 105:11790-11795. http://dx.doi.org/10.1073/pnas.0803711105.
108. Trotard M, Lepère-Douard C, Régeard M, Piquet-Pellorce C, Lavillette D, Cosset FL, Gripon P, Le Seyec J. 2009. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J 23:3780-3789. http://dx.doi.org/10.1096/fj.09-131920.
109. Traub LM. 2009. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol 10:583-596. http://dx.doi.org/10.1038/nrm2751.
110. Motley AM, Berg N, Taylor MJ, Sahlender DA, Hirst J, Owen DJ, Robinson MS. 2006. Functional Analysis of AP-2 α and μ2 subunits. Mol Biol Cell 17:5298-5308. http://dx.doi.org/10.1091/mbc.E06-05-0452.
111. Kazazic M, Bertelsen V, Pedersen KW, Vuong TT, Grandal MV, Rødland MS, Traub LM, Stang E, Madshus IH. 2009. Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrincoated pits. Traffic 10:235-245. http://dx.doi.org/10.1111/j.1600-0854.2008.00858.x.
112. Benmerah A, Bègue B, Dautry-Varsat A, Cerf-Bensussan N. 1996. The ear-of-adaptin interacts with the COOH-terminal domain of the Eps15 protein. J Biol Chem 271:12111-12116. http://dx.doi.org/10.1074/jbc.271.20.12111.
113. Chen H, Fre S, Slepnev VI, Capua MR, Takei K, Butler MH, Di Fiore PP, De Camilli P. 1998. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature 394:793-797. http://dx.doi.org/10.1038/29555.
114. Carbone R, Fré S, Iannolo G, Belleudi F, Mancini P, Pelicci PG, Torrisi MR, Di Fiore PP. 1997. eps15 and eps15R are essential components of the endocytic pathway. Cancer Res 57:5498-5504.
115. van Bergen en Henegouwen PM. 2009. Eps15: a multifunctional adaptor protein regulating intracellular trafficking. Cell Commun Signal 7:24. http://dx.doi.org/10.1186/1478-811X-7-24.
116. Black ML. 1963. Sequential blockage as a theoretical basis for drug synergism. JMed Chem 6:145-153. http://dx.doi.org/10.1021/jm00338a014.
117. Ricotta D, Hansen J, Preiss C, Teichert D, Höning S. 2008. Characterization of a protein phosphatase 2A holoenzyme that dephosphorylates the clathrin adaptors AP-1 and AP-2. J Biol Chem 283:5510-5517. http://dx.doi.org/10.1074/jbc.M707166200.